Altered vascular homeostasis in chronic kidney disease

Clinical Hemorheology and Microcirculation

Volumn 38, Issue 3, 2008, Pages 201-207

  Futrakul, Narisa ^a   Butthep, Punnee ^b   Futrakul, Prasit ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Angiopoietin; Chronic kidney disease; Hemodynamic maladjustment; Renal microvascular disease vascular homeostasis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HOMEOSTASIS; HUMAN; HUMAN CELL; KIDNEY BLOOD VESSEL; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY PERFUSION; MICROANGIOPATHY; TISSUE REGENERATION; VASCULAR ENDOTHELIUM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMODYNAMICS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; KIDNEY TUBULES; MICROCIRCULATION; RENAL CIRCULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38749118294     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. A.C. Bohle, S. Mackensen-Haen and M. Wehrmann, Significance of postglomerular capillaries in the pathogenesis of chronic renal failure, Kidney Blood Press. Res. 19 (1996), 191-195.
2. P. Futrakul, V. Sitprija, S. Yenrudi, M. Poshyachinda, R. Sensirivatana, D. Watana et al., Glomerular endothelial dysfunction determines disease progression: a hypothesis, Am. J. Nephrol. 17 (1997), 533-540.
3. D.H. Kang, J. Kanellis, C. Hugo, L. Truong, S. Anderson, D. Kerjaschki et al., Role of the microvascular endothelium in progressive renal disease, J. Am. Soc. Nephrol. 13 (2002), 806-816.
4. Y. Ishii, T. Sawada, K. Kubota, S. Fuchinoue, S. Teraoka and A. Shimiza, Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy, Kidney Int. 67 (2005), 321-332.
5. T. Nakagawa, D.H. Kang, R. Ohashi, S.I. Suga, J. Herrera-Acosta, B. Rodrigueq-Iturbe et al., Tubulointerstitial disease: role of ischemia and microvasular disease, Cur. Opin. Nephrol. Hyperten. 12 (2003), 233-241.
6. M. Mazzali, A.J. Jefferson, Z. Ni, N.D. Vaziri and R.J. Johnson, Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension, Kidney Int. 63 (2003), 2088-2093.
7. D.P. Basile, Rare faction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy, Cur. Opin. Nephrol. Hyperten. 13 (2004), 1-7.
8. L.D. Truong, A. Farhood, J. Tasby and D. Gillum, Experimental chronic ischemia: Morphologic and immunologic studies, Kidney Int. 41 (1992), 1676-1689.
9. P. Futrakul, M. Poshyachinda, S. Yenrudi, P. Salikul, R. Sensirivatana, N. Futrakul et al., Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: Therapeutic benefit with vasodilator, J. Med. Assoc. Thai. 75 (1992), 375-385.
10. N. Futrakul, A. Laohaphaibul and P. Futrakul, Glomerular endothelial dysfunction and hemodynamic maladjustment in severe vesicoureteric reflux, Ren. Fail. 25 (2003), 479-483.
11. N. Futrakul, P. Futrakul and P. Siriviriyakul, Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis, Clin. Hemorheol. Microcirc. 31 (2004), 197-205.
12. N. Futrakul, S. Yenrudi, R. Sensirivatana, D. Watana, A. Laohapaibul, K. Watanapenphaibul et al., Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome, Ren. Fail. 22 (2000), 329-335.
13. A. Solovey, Y. Lin, P. Browne et al., Circulating activated endothelial cells in sickle cell anemia, N. Engl. J. Med. 337 (1997), 1584-1590.
14. N. Futrakul, W. Kittikowit and S. Yenrudi, Reduced endothelial factor VIII staining in renal microcirculation correlates with hemodynamic alteration in nephrosis, Ren. Fail. 25 (2003), 759-764.
15. N. Futrakul, M. Sila-asna and P. Futrakul, Therapeutic strategy towards renal restoration in chronic kidney disease, Asian Biomed. 1 (2007), 33-44.
16. M. Sila-asna, A. Bunyaratvej, P. Futrakul and N. Futrakul, Renal microvascular abnormality in chronic kidney disease, Ren. Fail. 28 (2006), 609-612.
17. A.I. Nykanen, R. Krebs, A. Snaristo et al., Angiopoietin-1 protects against the development of cardiac allograft arteriolosclerosis, Circulation 107 (2003), 1308-1314.
18. P. Ruggenenti, A. Perna, G. Gheravdi, G. Garini, C. Zoccali, C. Zoccali et al., Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria, Lancet 354 (1999), 359-364.
19. The HOPE Investigators, Effects of vamipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: result of the HOPE study and MICRO-HOPE Substudy, Lancet 355 (2000), 253-259.
20. C.E. Mogensen, S. Neldam, I. Jikkanen, S. Clren, R. Viskoper, R.I. Watts et al., Randomized controlled trial of dual blockade of rennin-angiotensin system in patients with hypertension, microalbuminuria, an non-insulin dependent diabetes: the candesatan and lisonopril microalbuminuria (CALM) study, BMJ 321 (2000), 1440-1443.
21. K. Rossing, P. Jacobsen, L. Pietraszek and H.-H. Perving, Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy, Diabetes Care 26 (2003), 2268-2274.
22. G. Deterrari, M. Ravean, V. Bersuti, G. Leoncini and L. Deferran, Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment, J. Am. Soc. Nephrol. 15 (2004), S6-S11.
23. P. Futrakul, S. Yenrudi, N. Futrakul, R. Sensirivatana, P. Kingwatanakul, J. Jungthirapanich et al., Tubular function and tubulointerstitial disease, Am. J. Kidney Dis. 33 (1999), 886-891.
24. N. Futrakul, P. Futrakul and P. Siriviriyakul, Correction of peritubular capillary flow reduction with vasodilators restores function n focal segmental glomerulosclerotic nephrosis, Clin. Hemorheol. Microcirc. 31 (2004), 197-205.
25. N. Futrakul, P. Butthep, V. Vongthavarawat, P. Futrakul, S. Sirisalipoch, T. Chaivatanarat et al., Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy, Clin. Hemorheol. Microcirc. 34 (2006), 373-382.